{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:50:08Z","timestamp":1791067808420,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"vor","delay-in-days":1052,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.clindermatol.2013.01.008","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T10:28:51Z","timestamp":1372156131000},"page":"413-422","source":"Crossref","is-referenced-by-count":100,"title":["Kaposi\u2019s sarcoma: Etiology and pathogenesis, inducing factors, causal associations, and treatments: Facts and controversies"],"prefix":"10.1016","volume":"31","author":[{"given":"Eleonora","family":"Ruocco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lina","family":"Tornesello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronni","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco M.","family":"Buonaguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2013.01.008_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01830024","article-title":"Idiopathisches multiples Pigmentsarkom der Haut","volume":"4","author":"Kaposi","year":"1872","journal-title":"Arch Dermatol Syph"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0010","first-page":"295","article-title":"L'angiosarcomatose de Kaposi au Congo belge et au Ruanda-Urundi","volume":"37","author":"Thijs","year":"1957","journal-title":"Ann Soc Belge Med Trop (1920)"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0015","first-page":"330","article-title":"Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes","volume":"18","author":"Oettle","year":"1962","journal-title":"Acta Unio Int Contra Cancrum"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/1097-0142(197808)42:2<442::AID-CNCR2820420210>3.0.CO;2-2","article-title":"Kaposi's sarcoma in renal allograft recipients","volume":"42","author":"Stribling","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0025","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/1097-0142(19800315)45:6<1472::AID-CNCR2820450629>3.0.CO;2-A","article-title":"Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications","volume":"45","author":"Safai","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0030","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0140-6736(81)92740-9","article-title":"Kaposi's sarcoma in homosexual men-a report of eight cases","volume":"2","author":"Hymes","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0140-6736(90)90001-L","article-title":"Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?","volume":"335","author":"Beral","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0040","first-page":"1","article-title":"Kaposi's sarcoma: a natural model of interrelationships between viruses, immunologic responses, genetics, and oncogenesis","volume":"32","author":"Giraldo","year":"1983","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0045","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/jnci\/49.6.1495","article-title":"Kaposi's sarcoma: a new model in the search for viruses associated with human malignancies","volume":"49","author":"Giraldo","year":"1972","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0050","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/jnci\/49.6.1509","article-title":"Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions","volume":"49","author":"Giraldo","year":"1972","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ijc.2910260105","article-title":"Kaposi's sarcoma and its relationship to cytomegalovirus (CMV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma","volume":"26","author":"Giraldo","year":"1980","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0060","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/(SICI)1097-0215(19960103)65:1<25::AID-IJC5>3.0.CO;2-3","article-title":"Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies","volume":"65","author":"Buonaguro","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/sti.2005.016568","article-title":"HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study","volume":"82","author":"Casper","year":"2006","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0075","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/00002030-200308150-00001","article-title":"Human herpesvirus 8 epidemiology: what we do and do not know","volume":"17","author":"Dukers","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jnci\/90.5.395","article-title":"Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy","volume":"90","author":"Whitby","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0085","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/1097-0215(20001215)88:6<1003::AID-IJC26>3.0.CO;2-9","article-title":"Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta","volume":"88","author":"Engels","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0090","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1086\/598523","article-title":"Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission","volume":"199","author":"De Sanjose","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0095","first-page":"230","article-title":"Kaposi's sarcoma revisited","volume":"9","author":"Szajerka","year":"2007","journal-title":"AIDS Rev"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcv.2007.06.013","article-title":"Evaluation of global clustering patterns and strain variation over an extended ORF26 gene locus from Kaposi's sarcoma herpesvirus","volume":"40","author":"Zong","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0105","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1128\/JVI.73.5.4156-4170.1999","article-title":"High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations","volume":"73","author":"Zong","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0110","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1128\/JVI.73.8.6646-6660.1999","article-title":"Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end","volume":"73","author":"Poole","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0115","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1086\/315456","article-title":"Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype","volume":"181","author":"Biggar","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0120","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1099\/0022-1317-79-12-3055","volume":"79","author":"Kasolo","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000089374","article-title":"Ugandan Kaposi's sarcoma-associated herpesvirus phylogeny: evidence for cross-ethnic transmission of viral subtypes","volume":"49","author":"Kajumbula","year":"2006","journal-title":"Intervirology"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0130","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/jmv.21322","article-title":"HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma","volume":"80","author":"Mancuso","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1099\/vir.0.19465-0","article-title":"Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations","volume":"85","author":"Whitby","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0140","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virol.2009.12.005","article-title":"Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS era","volume":"398","author":"Tornesello","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0145","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.virusres.2011.09.027","article-title":"Molecular epidemiology of human herpesvirus 8 variants in Kaposi's sarcoma from Iranian patients","volume":"163","author":"Jalilvand","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jso.20090","article-title":"Kaposi's sarcoma: an update","volume":"87","author":"Schwartz","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0155","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/ijc.22233","article-title":"Kaposi's sarcoma risk among transplant recipients in the United States (1993\u20132003)","volume":"119","author":"Mbulaiteye","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0160","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.annepidem.2010.07.098","article-title":"Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology","volume":"20","author":"Pfeiffer","year":"2010","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-9378-5-23","article-title":"Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily","volume":"5","author":"Goedert","year":"2010","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1158\/1055-9965.EPI-04-0598","article-title":"A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma","volume":"14","author":"Brown","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0175","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/JVI.80.2.697-709.2006","article-title":"Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function","volume":"80","author":"Si","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0180","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1242\/jcs.114.23.4139","article-title":"The p53 functional circuit","volume":"114","author":"Jin","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0185","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/sj.onc.1210302","article-title":"TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes","volume":"26","author":"Petitjean","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0190","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/47266","article-title":"p53 inhibition by the LANA protein of KSHV protects against cell death","volume":"402","author":"Friborg","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0195","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1128\/JVI.02353-08","article-title":"Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway","volume":"83","author":"Lee","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1568009053332636","article-title":"MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy","volume":"5","author":"Rayburn","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0205","first-page":"1","article-title":"Regulation of the p53 protein by the MDM2 oncoprotein\u2014thirty-eighth G.H.A. Clowes Memorial Award Lecture","volume":"59","author":"Freedman","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0210","first-page":"2231","article-title":"p53 Mutation and MDM2 amplification in human soft tissue sarcomas","volume":"53","author":"Leach","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0215","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","article-title":"A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans","volume":"119","author":"Bond","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0220","doi-asserted-by":"crossref","first-page":"26776","DOI":"10.1074\/jbc.M505203200","article-title":"A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells","volume":"280","author":"Arva","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jmg.2005.037952","article-title":"Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome","volume":"43","author":"Bougeard","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.ejhg.5201715","article-title":"R et al. The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes","volume":"15","author":"Ruijs","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0235","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1158\/0008-5472.CAN-06-0180","article-title":"MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner","volume":"66","author":"Bond","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0240","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ijc.21872","article-title":"Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer","volume":"119","author":"Lind","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jnci\/djj054","article-title":"Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status","volume":"98","author":"Menin","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/1354750X.2010.525664","article-title":"MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients","volume":"16","author":"Tornesello","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF02787352","article-title":"Lymphoid disorders associated with HHV-8\/KSHV infection: facts and contentions","volume":"16","author":"Gaidano","year":"1999","journal-title":"Med Oncol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0260","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3324\/haematol.2009.007260","article-title":"Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1\/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma","volume":"94","author":"Boulanger","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0265","first-page":"789","article-title":"Incidence rates of cancer in Kyandondo County, Uganda, 1954\u20131960","volume":"35","author":"Davies","year":"1965","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0270","first-page":"865","article-title":"Cancer in Kyadondo County, Uganda, 1968\u201370","volume":"48","author":"Templeton","year":"1972","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0275","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijc.2910540106","article-title":"Cancer in Kampala, Uganda, in 1989\u201391: changes in incidence in the era of AIDS","volume":"54","author":"Wabinga","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6600745","article-title":"Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma","volume":"88","author":"Dedicoat","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0285","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12038-008-0084-x","article-title":"Multifactorial etiology of Kaposi' sarcoma: a hypothesis","volume":"33","author":"Haverkos","year":"2008","journal-title":"J Biosci"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0290","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/0140-6736(93)92252-O","article-title":"Endemic Kaposi's sarcoma in Africa and local volcanic soils","volume":"342","author":"Ziegler","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0295","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-4362.1984.tb05664.x","article-title":"Kaposi's sarcoma on a lymphedematous immunocompromised limb","volume":"23","author":"Ruocco","year":"1984","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0300","first-page":"153","article-title":"Linfostasi: importante fattore patogenetico nel sarcoma di Kaposi classico","volume":"46","author":"Ruocco","year":"1992","journal-title":"Ann Ital Dermatol Clin Sper"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0305","first-page":"283","article-title":"Anomalies r\u00e9gionales des voies lymphatiques et de la r\u00e9ponse au D.N.C.B. dans le sarcome de Kaposi classique","volume":"112","author":"Ruocco","year":"1985","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2133.2000.03259.x","article-title":"Penile Kaposi's sarcoma preceded by chronic penile lymphoedema","volume":"142","author":"Schwartz","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0315","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2133.2000.03364.x","article-title":"Acquired immune deficiency syndrome-related hyperkeratotic Kaposi's sarcoma with severe lymphoedema: report of five cases","volume":"142","author":"Hengge","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0320","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-4362.1989.tb02529.x","article-title":"Kaposi's sarcoma. A lymphologic perspective","volume":"28","author":"Witte","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1067\/mjd.2002.120909","article-title":"Lymphedema: an immunologically vulnerable site for development of neoplasms","volume":"47","author":"Ruocco","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0330","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000321193","article-title":"Kaposi's sarcoma after repeated surgical procedures in an immunocompetent patient: the lymphatic hypothesis","volume":"221","author":"Kostaki","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0335","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000330322","article-title":"Kaposi's sarcoma restricted to an immunocompromised district","volume":"223","author":"Ruocco","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0340","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1038\/sj.onc.1207822","article-title":"Viruses, chemicals and co-carcinogenesis","volume":"23","author":"Haverkos","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0345","first-page":"306","article-title":"Viruses as tumor initiators and tumor promoters","volume":"29","author":"zur Hausen","year":"1985","journal-title":"Haematol Blood Transfus"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0350","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000419723","article-title":"Prospected etiopathogenic mechanisms of AIDS-associated tumors","volume":"43","author":"Buonaguro","year":"1991","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0355","first-page":"143","article-title":"Viruses and cancer","volume":"5","author":"Cuzick","year":"2000","journal-title":"J Epidemiol Biostat"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0360","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2888","article-title":"Kaposi's sarcoma and its associated herpesvirus","volume":"10","author":"Mesri","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0365","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1289\/ehp.94102858","article-title":"Nitrite inhalants: history, epidemiology, and possible links to AIDS","volume":"102","author":"Haverkos","year":"1994","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0370","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/em.2850210307","article-title":"Mutagenicity of iso-butyl nitrite vapor in the Ames test and some relevant chemical properties, including the reaction of iso-butyl nitrite with phosphate","volume":"21","author":"Mirvish","year":"1993","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0375","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1468-3083.2003.00670.x","article-title":"Kaposi's sarcoma: aetiopathogenesis, histology and clinical features","volume":"17","author":"Buonaguro","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0380","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaad.2008.05.001","article-title":"Kaposi sarcoma: a continuing conundrum","volume":"59","author":"Schwartz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0385","unstructured":"WHO. Malaria treatment guidelines 2010. Washington DC: WHO."},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0390","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1475-2875-8-174","article-title":"Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon","volume":"8","author":"Sayang","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0395","series-title":"UMSP sentinel site malaria surveillance report July 2010","year":"2010"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0400","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ijc.22205","article-title":"Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions","volume":"120","author":"Whitby","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0405","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaad.2009.12.016","article-title":"Kaposi sarcoma and quinine: a potentially overlooked triggering factor in millions of Africans","volume":"64","author":"Ruocco","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0410","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/BOR.0b013e32834456bf","article-title":"Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action","volume":"23","author":"Katz","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0415","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJM198601303140504","article-title":"Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine","volume":"314","author":"Pappaioanou","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0420","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/590567","article-title":"The 1918 \"Spanish flu\" in Spain","volume":"47","author":"Trilla","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0425","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000409717","article-title":"Does quinine facilitate AIDS?","volume":"32","author":"Ruocco","year":"1983","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0430","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1046\/j.1365-2133.2002.507116.x","article-title":"Possible causal role of lisinopril in a case of Kaposi's sarcoma","volume":"147","author":"Bilen","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0435","first-page":"31","article-title":"Kaposi's sarcoma in a patient with psoriasis vulgaris","volume":"19","author":"Dervis","year":"2010","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0440","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/rheumatology\/keh398","article-title":"The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis","volume":"44","author":"Dalbeth","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0445","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1172\/JCI1560","article-title":"Nitric oxide synthase modulates angiogenesis in response to tissue ischemia","volume":"101","author":"Murohara","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0450","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1172\/JCI119451","article-title":"Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis","volume":"99","author":"Ziche","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0455","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1034\/j.1399-3003.2000.016003452.x","article-title":"Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms","volume":"16","author":"Hayashi","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0460","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/1471-2407-10-370","article-title":"Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells","volume":"10","author":"Sasaki","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0465","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5732\/cjc.011.10056","article-title":"Chloroquine enhances the cytotoxicity of topotecan by inhibiting autophagy in lung cancer cells","volume":"30","author":"Wang","year":"2011","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0470","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: cellular and molecular mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0475","first-page":"1124","article-title":"The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus","volume":"159","author":"Wozniacka","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0480","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S1807-59322011000100014","article-title":"IL-2, IL-5, TNF-alpha and IFN-gamma mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions","volume":"66","author":"Carneiro","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0485","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2007.05.015","article-title":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century","volume":"30","author":"Rolain","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0490","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-4632.2006.02696.x","article-title":"Quinine sulfate inhibits invasion of some bacterial skin pathogens","volume":"45","author":"Wolf","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0495","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jdermsci.2007.05.009","article-title":"Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: analysis of the molecular mechanisms involved","volume":"47","author":"Baroni","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0500","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D38WS167FR","article-title":"Quinine sulfate and HSV replication","volume":"9","author":"Wolf","year":"2003","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0505","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1128\/JVI.77.14.7978-7990.2003","article-title":"Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis","volume":"77","author":"Akula","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0510","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.4049\/jimmunol.162.6.3672","volume":"162","author":"Murakami-Mori","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0515","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.intimp.2010.04.016","article-title":"Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab","volume":"10","author":"Ursini","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0520","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0140-6736(05)63025-5","article-title":"Inhibition of angiogenesis in Kaposi's sarcoma by captopril","volume":"349","author":"Vogt","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0525","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(81)91777-3","article-title":"Immunosuppressive action of captopril blocked by prostaglandin synthetase inhibitor","volume":"1","author":"Johnsen","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0530","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1161\/01.CIR.99.23.3043","article-title":"Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo","volume":"99","author":"Fabre","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0535","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0162-3109(96)00160-9","article-title":"Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-alpha in vitro and in vivo","volume":"36","author":"Fukuzawa","year":"1997","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0540","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1245\/s10434-011-1860-7","article-title":"Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial","volume":"19","author":"Curatolo","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0545","first-page":"329","article-title":"Radiotherapy in the management of Kaposi's sarcoma","volume":"29","author":"Becker","year":"2006","journal-title":"Onkologie"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0550","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1200\/JCO.2008.16.8252","article-title":"AIDS-related malignancies: state of the art and therapeutic challenges","volume":"26","author":"Spano","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0555","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/apc.2005.19.635","article-title":"Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome","volume":"19","author":"Leidner","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0560","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.seminoncol.2004.08.003","article-title":"Use of liposomal anthracyclines in Kaposi's sarcoma","volume":"31","author":"Krown","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0565","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/01.aids.0000189855.06194.ce","article-title":"Evidence of activity of Irinotecan in patients with advanced AIDS-related Kaposi's sarcoma","volume":"19","author":"Vaccher","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0570","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study","volume":"24","author":"Dezube","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0575","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2000.18.13.2593","article-title":"Activity of thalidomide in AIDS-related Kaposi's sarcoma","volume":"18","author":"Little","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0580","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1615\/CritRevImmunol.v27.i5.10","article-title":"Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity","volume":"27","author":"Yarchoan","year":"2007","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.clindermatol.2013.01.008_bb0585","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1200\/JCO.2005.06.079","article-title":"Imatinib-induced regression of AIDS-related Kaposi's sarcoma","volume":"23","author":"Koon","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13000096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13000096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T15:48:35Z","timestamp":1688312915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X13000096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":117,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0738081X13000096"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2013.01.008","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}